Education
About Us
Working with TipRanks
Follow Us
Accendra Health (ACH)
NYSE:ACH
Total Valuation
Accendra Health has a market cap or net worth of $166.30M. The enterprise value is $2.53B.
Market Cap$166.30M
Enterprise Value$2.53B
Share Statistics
Accendra Health has 77,346,596 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding77,346,596
Owned by Insiders20.72%
Owned by Institutions33.63%
Financial Efficiency
Accendra Health’s return on equity (ROE) is -0.64 and return on invested capital (ROIC) is -7.46%.
Return on Equity (ROE)-0.64
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-7.46%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee461.24K
Profits Per Employee-15.63K
Employee Count23,200
Asset Turnover2.30
Inventory Turnover7.49
Valuation Ratios
The current PE Ratio of Accendra Health is ―. Accendra Health’s PEG ratio is -0.00364.
PE Ratio―
PS Ratio0.09
PB Ratio1.77
Price to Fair Value1.77
Price to FCF-15.04
Price to Operating Cash Flow0.00
PEG Ratio-0.00364
Income Statement
In the last 12 months, Accendra Health had revenue of 10.70B and earned -362.69M in profits. Earnings per share was -118.25.
Revenue10.70B
Gross Profit2.22B
Operating Income-207.77M
Pretax Income-357.36M
Net Income-362.69M
EBITDA515.18M
Earnings Per Share (EPS)-118.25
Cash Flow
In the last 12 months, operating cash flow was -98.97M and capital expenditures -253.22M, giving a free cash flow of -352.19M billion.
Operating Cash Flow-98.97M
Free Cash Flow-352.19M
Free Cash Flow per Share-4.55
Dividends & Yields
Accendra Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)1.77M
Important Dates
Accendra Health upcoming earnings date is Feb 25, 2026, Before Open (Confirmed).
Last Earnings DateOct 30, 2025
Next Earnings DateFeb 25, 2026
Ex-Dividend Date―
Financial Position
Accendra Health as a current ratio of 1.08, with Debt / Equity ratio of -511.43%
Current Ratio1.08
Quick Ratio0.47
Debt to Market Cap1.84
Net Debt to EBITDA35.40
Interest Coverage Ratio-1.44
Taxes
In the past 12 months, Accendra Health has paid 5.33M in taxes.
Income Tax5.33M
Effective Tax Rate-0.01
Enterprise Valuation
Accendra Health EV to EBITDA ratio is 52.39, with an EV/FCF ratio of -46.40.
EV to Sales0.29
EV to EBITDA52.39
EV to Free Cash Flow-46.40
EV to Operating Cash Flow19.15
Balance Sheet
Accendra Health has $32.84M in cash and marketable securities with $2.20B in debt, giving a net cash position of -$2.16B billion.
Cash & Marketable Securities$32.84M
Total Debt$2.20B
Net Cash-$2.16B
Net Cash Per Share-$27.98
Tangible Book Value Per Share-$13.85
Margins
Gross margin is 26.13%, with operating margin of -1.94%, and net profit margin of -3.39%.
Gross Margin26.13%
Operating Margin-1.94%
Pretax Margin-3.34%
Net Profit Margin-3.39%
EBITDA Margin0.55%
EBIT Margin2.34%
Analyst Forecast
The average price target for Accendra Health is $3.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$3.50
Price Target Upside48.31% Upside
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―